Familial necrobiosis lipoidica not associated with diabetes

Dermatology Online Journal

Volumn 13, Issue 3, 2007, Pages

  Roche Gamón, Elena ^a   Vilata Corell, Juan J ^a   Velasco Pastor, Manuel ^a  

^a HOSPITAL GENERAL UNIVERSITARIO DE VALENCIA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; FUMARIC ACID; GLUCOSE; PENTOXIFYLLINE;

ADULT; ARTICLE; ATROPHIC SKIN DISEASE; CASE REPORT; DIABETES MELLITUS; DIET RESTRICTION; DISEASE ASSOCIATION; DRUG WITHDRAWAL; ERYTHEMA; FAMILIAL DISEASE; FEMALE; FLUSHING; FOLLOW UP; GASTROINTESTINAL SYMPTOM; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; LEG; NECROBIOSIS LIPOIDICA; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL GLUCOSE TOLERANCE TEST; RELATIVE; SIDE EFFECT; SKIN BIOPSY; SYMPTOM; TELANGIECTASIA; URINALYSIS; DIFFERENTIAL DIAGNOSIS; GENETIC PREDISPOSITION; GENETICS; METABOLISM; MIDDLE AGED;

ADULT; BLOOD GLUCOSE; DIABETES MELLITUS; DIAGNOSIS, DIFFERENTIAL; FEMALE; FOLLOW-UP STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MIDDLE AGED; NECROBIOSIS LIPOIDICA;

EID: 34547191231     PISSN: None     EISSN: 10872108     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Rollins TG, Winkelmann RK. Necrobiosis lipoidica granulomatosis. Necrobiosis lipoidica diabeticorum in the nondiabetic. Arch Dermatol 1960;82:537-543.
2. Muller SA, Winkelmann RK. Necrobiosis lipoidica diabeticorum. A clinical and pathological investigation of 171 cases. Arch Dermatol 1966;93:272-281.
3. Ellenberg M. Diabetic complications without manifest diabetes. JAMA 1963;183:926-930.
4. Verrotti A, Chiarelli F, Amerio P, Morgese G. Necrobiosis lipoidica diabeticorum in children and adolescents: a clue for underlying renal and retinal disease. Pediatr Dermatol 1995;12:220-223.
5. Lowitt MH, Dover JS. Necrobiosis lipoidica. J Am Acad Dermatol 1991;25:735-748.
6. Csaszar A, Daroczy J, Szenasi P, Anda L, Toth L, Hosszufalusi N, Karadi I, Kalabay L, Romics L. Necrobiosis lipoidica without diabetes mellitus (diagnostic and therapeutic possibilities). [Article in Hungarian]. Orv Hetil 1989;130:2141-2145.
7. Wee SA, Possick P. Necrobiosis lipoidica. Dermatol Online J 2004;10:18.
8. O'Toole EA, Kennedy U, Nolan JJ, Young MM, Rogers S, Barnes L. Necrobiosis lipoidica: only a minority of patients have diabetes mellitus. Br J Dermatol 1999;140:283-286.
9. Seviour PW, Elkeles RS. Necrobiosis lipoidica in two diabetic sisters. Clin Exp Dermatol 1985;10:159-161.
10. Findlay GH, Morrison JG, de Beer HA. Non-diabetic necrobiosis lipoidica. Hitherto unrecognized papulonecrotic, nodulo-ulcerative and familial forms of the disease. S Afr Med J 1981;59:323-326.
11. Ho KK, O'Loughlin S, Powell FC. Familial non-diabetic necrobiosis lipoidica. Australas J Dermatol 1992;33:31-34.
12. Cohen O, Yaniv R, Karasik A, Trau H. Necrobiosis lipoidica and dibetic control revisited. Med Hypotheses 1996;46:348-350.
13. Leal Hernandez M, Abellan Aleman J, Vicente Martinez R, Martinez Crespo J. Lipoid necrobiosis in an asymptomatic patient: marker of cardiovascular risk? [Article in Spanish]. Aten Primaria 2004;33:474-475.
14. Boyd AS. Tretinoin treatment of necrobiosis lipoidica diabeticorum. Diabetes Care 1999;22:1753-1754.
15. Noz KC, Korstanje MJ, Vermeer BJ. Ulcerating necrobiosis lipoidica effectively treated with pentoxifylline. Clin Exp Dermatol 1993;18:78-79.
16. De Rie MA, Sommer A, Hoekzema R, Neumann HA. Treatment of necrobiosis lipoidica with topical psoralen plus ultraviolet A. Br J Dermatol 2002;147:743-747.
17. Stanway A, Rademaker M, Newman P. Healing of severe ulcerative necrobiosis lipoidica with cyclosporin. Australas J Dermatol 2004;45:119-122.
18. Kreuter A, Knierim C, Stucker M, Pawlak F, Rotterdam S, Altmeyer P, Gambichler T. Fumaric acid esters in necrobiosis lipoidica: results of a prospective noncontrolled study. Br J Dermatol 2005;153:802-807.
19. Harth W, Linse R. Topical tacrolimus in granuloma annulare and necrobiosis lipoidica. Br J Dermatol 2004;150:792-794.
20. Kolde G, Muche JM, Schulze P, Fischer P, Lichey J. Infliximab: a promising new treatment option for ulcerated necrobiosis lipoidica. Dermatology 2003;206;180-181.